Evaluation of (4‐Arylpiperidin‐1‐yl)cyclopentanecarboxamides As High‐Affinity and Long‐Residence‐Time Antagonists for the CCR2 Receptor. Issue 7 (1st June 2015)
- Record Type:
- Journal Article
- Title:
- Evaluation of (4‐Arylpiperidin‐1‐yl)cyclopentanecarboxamides As High‐Affinity and Long‐Residence‐Time Antagonists for the CCR2 Receptor. Issue 7 (1st June 2015)
- Main Title:
- Evaluation of (4‐Arylpiperidin‐1‐yl)cyclopentanecarboxamides As High‐Affinity and Long‐Residence‐Time Antagonists for the CCR2 Receptor
- Authors:
- Vilums, Maris
Zweemer, Annelien J. M.
Dilanchian, Arian
van Veldhoven, Jacobus P. D.
de Vries, Henk
Brussee, Johannes
Saunders, John
Stamos, Dean
Heitman, Laura H.
IJzerman, Adriaan P. - Abstract:
- <abstract abstract-type="main" xml:lang="en"> <title>Abstract</title> <p>Animal models suggest that the chemokine ligand 2/CC‐chemokine receptor 2 (CCL2/CCR2) axis plays an important role in the development of inflammatory diseases. However, CCR2 antagonists have failed in clinical trials because of a lack of efficacy. We previously described a new approach for the design of CCR2 antagonists by the use of structure–kinetics relationships (SKRs). Herein we report new findings on the structure–affinity relationships (SARs) and SKRs of the reference compound MK‐0483, its diastereomers, and its structural analogues as CCR2 antagonists. The SARs of the 4‐arylpiperidine group suggest that lipophilic hydrogen‐bond‐accepting substituents at the 3‐position are favorable. However, the SKRs suggest that a lipophilic group with a certain size is desired [e.g., 3‐Br: <italic>K</italic><sub>i</sub>=2.8 n<sc>M</sc>, residence time (<italic>t</italic><sub>res</sub>)=243 min; 3‐<italic>i</italic>Pr: <italic>K</italic><sub>i</sub>=3.6 n<sc>M</sc>, <italic>t</italic><sub>res</sub>=266 min]. Alternatively, additional substituents and further optimization of the molecule, while keeping a carboxylic acid at the 3‐position, can also prolong <italic>t</italic><sub>res</sub>; this was most prominently observed in MK‐0483 (<italic>K</italic><sub>i</sub>=1.2 n<sc>M</sc>, <italic>t</italic><sub>res</sub>=724 min) and a close analogue (<italic>K</italic><sub>i</sub>=7.8 n<sc>M</sc>) with a short<abstract abstract-type="main" xml:lang="en"> <title>Abstract</title> <p>Animal models suggest that the chemokine ligand 2/CC‐chemokine receptor 2 (CCL2/CCR2) axis plays an important role in the development of inflammatory diseases. However, CCR2 antagonists have failed in clinical trials because of a lack of efficacy. We previously described a new approach for the design of CCR2 antagonists by the use of structure–kinetics relationships (SKRs). Herein we report new findings on the structure–affinity relationships (SARs) and SKRs of the reference compound MK‐0483, its diastereomers, and its structural analogues as CCR2 antagonists. The SARs of the 4‐arylpiperidine group suggest that lipophilic hydrogen‐bond‐accepting substituents at the 3‐position are favorable. However, the SKRs suggest that a lipophilic group with a certain size is desired [e.g., 3‐Br: <italic>K</italic><sub>i</sub>=2.8 n<sc>M</sc>, residence time (<italic>t</italic><sub>res</sub>)=243 min; 3‐<italic>i</italic>Pr: <italic>K</italic><sub>i</sub>=3.6 n<sc>M</sc>, <italic>t</italic><sub>res</sub>=266 min]. Alternatively, additional substituents and further optimization of the molecule, while keeping a carboxylic acid at the 3‐position, can also prolong <italic>t</italic><sub>res</sub>; this was most prominently observed in MK‐0483 (<italic>K</italic><sub>i</sub>=1.2 n<sc>M</sc>, <italic>t</italic><sub>res</sub>=724 min) and a close analogue (<italic>K</italic><sub>i</sub>=7.8 n<sc>M</sc>) with a short residence time.</p> </abstract> … (more)
- Is Part Of:
- ChemMedChem. Volume 10:Issue 7(2015:Jul.)
- Journal:
- ChemMedChem
- Issue:
- Volume 10:Issue 7(2015:Jul.)
- Issue Display:
- Volume 10, Issue 7 (2015)
- Year:
- 2015
- Volume:
- 10
- Issue:
- 7
- Issue Sort Value:
- 2015-0010-0007-0000
- Page Start:
- 1249
- Page End:
- 1258
- Publication Date:
- 2015-06-01
- Subjects:
- Pharmaceutical chemistry -- Periodicals
615.19005 - Journal URLs:
- http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)1860-7187 ↗
http://www3.interscience.wiley.com/cgi-bin/jhome/110485305 ↗
http://onlinelibrary.wiley.com/ ↗ - DOI:
- 10.1002/cmdc.201500058 ↗
- Languages:
- English
- ISSNs:
- 1860-7179
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 3172.254000
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 3311.xml